BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27647227)

  • 61. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
    Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
    Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
    Jiang W; Guo MH; Hai X
    World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver disease in centrally obese but not in non-centrally obese patients with diabetes mellitus.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    Asia Pac J Clin Nutr; 2015; 24(2):289-98. PubMed ID: 26078246
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis.
    Petit JM; Pedro L; Guiu B; Duvillard L; Bouillet B; Jooste V; Habchi M; Crevisy E; Fourmont C; Buffier P; Hillon P; Cercueil JP; Verges B
    Diabet Med; 2015 Dec; 32(12):1648-51. PubMed ID: 25981893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk.
    Aneni EC; Oni ET; Martin SS; Blaha MJ; Agatston AS; Feldman T; Veledar E; Conçeicao RD; Carvalho JA; Santos RD; Nasir K
    J Hypertens; 2015 Jun; 33(6):1207-14. PubMed ID: 25693058
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum C1q/TNF-Related Protein 4 Levels are Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients.
    Han J; Fan H; Dai Y; Cheng X
    Metab Syndr Relat Disord; 2023 Apr; 21(3):163-168. PubMed ID: 36787473
    [No Abstract]   [Full Text] [Related]  

  • 69. Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.
    Shen H; Liangpunsakul S
    J Clin Gastroenterol; 2016 Aug; 50(7):596-601. PubMed ID: 26905606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nonalcoholic fatty liver disease in patients with type 2 diabetes.
    Younossi ZM; Gramlich T; Matteoni CA; Boparai N; McCullough AJ
    Clin Gastroenterol Hepatol; 2004 Mar; 2(3):262-5. PubMed ID: 15017611
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diurnal rhythm of follicle-stimulating hormone is associated with nonalcoholic fatty liver disease in a Chinese elderly population.
    Li X; Jing L; Lin F; Huang H; Chen Z; Chen Y; Wang L; Lin X; Guo T; Yang J; Ruan J; Lin K; Li C; You Z; He L; Chen J; Li Z; Zhu P; Chen G
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():166-170. PubMed ID: 29408750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association between non-alcoholic fatty liver disease with the susceptibility and outcome of COVID-19: A retrospective study.
    Wang G; Wu S; Wu C; Zhang Q; Wu F; Yu B; Zhang S; Wu C; Wu G; Zhong Y
    J Cell Mol Med; 2021 Dec; 25(24):11212-11220. PubMed ID: 34761514
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Prevalence rate and risk factor analysis of nonalcoholic fatty liver disease in 115 female patients with schizophrenia].
    Yu Y; Zhao J; Jin YL; Xie Q; Yao DF; Yao M
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):947-953. PubMed ID: 37872090
    [No Abstract]   [Full Text] [Related]  

  • 74. The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study.
    Xie J; Huang H; Liu Z; Li Y; Yu C; Xu L; Xu C
    Hepatology; 2023 Mar; 77(3):949-964. PubMed ID: 35971878
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pediatric Nonalcoholic Fatty Liver Disease in New York City: An Autopsy Study.
    Fernandes DM; Pantangi V; Azam M; Salomao M; Iuga AC; Lefkowitch JH; Gill J; Morotti R; Lavine JE; Mencin AA
    J Pediatr; 2018 Sep; 200():174-180. PubMed ID: 29903531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complex.
    Wang CW; Chuang HY; Liao KW; Yu ML; Dai CY; Chang WT; Tsai CH; Chiang HC; Huang PC
    Environ Int; 2019 Oct; 131():104978. PubMed ID: 31325714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
    Xing J; Guan X; Zhang Q; Chen S; Wu S; Sun X
    Obes Facts; 2021; 14(2):190-196. PubMed ID: 33780962
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome.
    Abdeldyem SM; Goda T; Khodeir SA; Abou Saif S; Abd-Elsalam S
    J Clin Lipidol; 2017; 11(4):915-919. PubMed ID: 28579247
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence of non-alcoholic fatty liver disease in the Russian Ural Eye and Medical Study and the Ural Very Old Study.
    Bikbov MM; Gilmanshin TR; Zainullin RM; Kazakbaeva GM; Iakupova EM; Fakhretdinova AA; Tuliakova AM; Panda-Jonas S; Gilemzianova LI; Khakimov DA; Miniazeva LA; Jonas JB
    Sci Rep; 2022 May; 12(1):7842. PubMed ID: 35551494
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease.
    Simon TG; Van Der Sloot KWJ; Chin SB; Joshi AD; Lochhead P; Ananthakrishnan AN; Xavier R; Chung RT; Khalili H
    Inflamm Bowel Dis; 2018 Sep; 24(10):2247-2257. PubMed ID: 29788077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.